Table 3.

HR HPV, HIV and cytology results at baseline and first follow-up

Baseline				First follow-up
Total (n=4043)				Total (n=3074)
HPV	n	%	(95% CI)	n	%	(95% CI)
Positive	696	17.2	(0.16 to 0.18)	438	14.3	(0.13 to 0.16)
Negative	2951	73	(0.72 to 0.74)	2595	84.4	(0.83 to 0.86)
Missing	396	9.8	(0.09 to 0.1)	41	1.3	(0.01 to 0.02)
HIV
Positive	718	17.8	(0.17 to 0.19)	552	18	(0.17 to 0.2)
Negative	3325	82.2	(0.81 to 0.83)	2522	82	(0.80 to 0.83)
Cytology
HSIL	139	3.4	(0.03 to 0.04)
LSIL	329	8.1	(0.07 to 0.09)
Negative	3548	87.8	(0.87 to 0.89)
Missing	27	0.7	(0.00 to 0.01)

HIV, human immunodeficiency virus; HPV, human papillomavirus; HR, high risk; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion.